Famar has unveiled plans to acquire the Pointe-Claire, Quebec, manufacturing site from Bayer’s consumer health division.

The Greece-based contract manufacturing organization (CMO) has a network of 11 sites in Europe, which supply a wide range of products to the industry, serving most international markets, with a broad customer base.

The company says the acquisition is an important step in its strategic growth plan. It is the first site Famar will operate in North America. With its FDA approval status, Pointe-Claire serves markets in both the U.S. and Canada.

Famar expects to close the transaction in early 2017, at which time the company is expected to have two FDA approved sites in their global network, the other one being in Europe.